advertisement
advertisement
a world-first clinical trial led by a team at queen’s university belfast (qub) has shown that the new treatment slows the progression of prostate cancer in men where the disease has spread to their bones.
advertisement
results of the adrrad trial, which tested the combined therapy on 30 patients aged between 40 and 80 over the past four years, were published in leading cancer journal clinical cancer research .
advertisement
the research was conducted by the academic prostate cancer team at the northern ireland cancer centre, belfast , as part of the movember centre of excellence in partnership with prostate cancer uk , (fastman coe).